ImmunoVec launched from stealth with up to $40.7M in ARPA-H EMBODY Award funding to develop a pioneering in vivo cell therapy for autoimmune diseases.
Amount Raised
$40.7 Million
Round Type
Grant
Los AngelesBiotechnologyTherapeuticsInvestors
Description
ImmunoVec, based in Los Angeles, CA, has received up to $40.7M from the ARPA-H EMBODY program. This funding aims to accelerate the development of their first-in-class in vivo cell therapy for autoimmune diseases. The project will collaborate with Johns Hopkins University and MD Anderson Cancer Center. The goal is to engineer natural killer cells to improve treatments for serious autoimmune diseases.
Quick answer
ImmunoVec raised $40.7 Million in a Grant round, dated October 8, 2025. Investors: Anthem Venture Partners. ImmunoVec is based in Los Angeles, California, United States.
- How much did ImmunoVec raise?
- ImmunoVec raised $40.7 Million in a Grant round on October 8, 2025.
- Who invested in ImmunoVec?
- Anthem Venture Partners is named as investors in this round.
- What does ImmunoVec do?
- ImmunoVec is a biotechnology company based in Los Angeles, CA, pioneering a novel approach to in vivo cell engineering.
- Where is ImmunoVec based and how big is it?
- ImmunoVec is based in Los Angeles, California, United States. Fundz records about 12 employees.
- Who are the decision-makers at ImmunoVec?
- Fundz holds 1 contact at ImmunoVec. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as ImmunoVec that raised within 45 days of this round, from Fundz verified event records.
- BeyondSpring raised $2M (Funding Round) on November 21, 2025.
- ClearPoint Neuro raised $18M on November 20, 2025.
- BioVaxys Technology Corp. raised $1.5M (Post-IPO Equity) on November 19, 2025.
- VahatiCor raised $23M (Series B) on November 18, 2025.
- FibroBiologics raised $4M on November 18, 2025.
- Bambusa Therapeutics raised an undisclosed amount (Series A) on November 17, 2025.
Who to call at ImmunoVec, and when
A new round usually means ImmunoVec is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ImmunoVec raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ImmunoVec, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ImmunoVec. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ImmunoVec raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ImmunoVec raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.